Ifpma

Edit

The innovation development and access pathway: A holistic approach to accelerating access to innovative medicines and vaccines (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 12 Dec 2025

) ... This is particularly acute in lower-resource settings ... IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on December 12, 2025, and is solely responsible for the information contained herein.

Edit

A new dawn in global health: UHC as the path toward national health stewardship (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 11 Dec 2025

[...] ... Disclaimer. IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on December 12, 2025, and is solely responsible for the information contained herein.

Edit

Statement at the fourth meeting of the open-ended Intergovernmental Working Group (IGWG 4) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 01 Dec 2025

On 1st December 2025 in Geneva, IFPMA delivered a statement at at the fourth meeting of the open-ended Intergovernmental Working Group (IGWG 4) on the WHO Pandemic Agreement ... IFPMA - International ...

Edit

Considerations on the use of reliance in clinical trials review (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 25 Nov 2025

) ... Attachments Original document Permalink. Disclaimer. IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on November 25, 2025, and is solely responsible for the information contained herein.

Edit

WIPO Committee on IP and Development (CDIP 35): Technology Transfer (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 21 Nov 2025

On 20 November 2025, IFPMA submitted a statement on technology transfer at the WIPO Committee on IP and Development (CDIP 35) in Geneva ... About IFPMA ... ifpma.org ... Elliot Dunster e.dunster@ifpma.org.

Edit

Health as an economic priority – building on momentum driven by the G20 South Africa Presidency (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 17 Nov 2025

IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published this content on November 17, 2025, and is ...

Edit

Biopharmaceutical CEOs Roundtable met in Berlin (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 12 Nov 2025

About IFPMA. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations ... ifpma.org ... Elliot Dunster e.dunster@ifpma.org.

Edit

WIPO Standing Committee on Patents (SCP 37): Technology Transfer (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 05 Nov 2025

On 5 November 2025, IFPMA delivered a statement on technology transfer at the WIPO Standing Committee on Patents (SCP 37) in Geneva ... IFPMA and ... About IFPMA ... ifpma.org ... Elliot Dunster e.dunster@ifpma.org.

Edit

WIPO Standing Committee on Patents (SCP 37): Patents and health (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 04 Nov 2025

On 4 November 2025, IFPMA delivered a statement on patents and health at the WIPO Standing Committee on Patents (SCP 37) in Geneva ... To address access concerns, recent IFPMA ... About IFPMA ... ifpma.org.

Edit

Statement on PABS Instrument at the third meeting of the open-ended Intergovernmental Working Group (IGWG 3) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 03 Nov 2025

On 3 November 2025 in Geneva, IFPMA delivered a statement at at the third meeting of the open-ended Intergovernmental Working Group (IGWG 3) on the WHO Pandemic Agreement ... IFPMA - International ...

Edit

75th WHO Regional Committee for Europe on the Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European Region 2016–2025 (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 31 Oct 2025

This statement is delivered on behalf of IFPMA and its European member organization EFPIA ... About IFPMA. IFPMA represents the innovative pharmaceutical ... ifpma.org ... Elliot Dunster e.dunster@ifpma.org.

Edit

Policy considerations for the development, regulation and adoption of biosimilars (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 27 Oct 2025

To fully realize this potential, IFPMA recommends the adoption of the following policy recommendations ... IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations published ...

Edit

76th Session of the WHO Regional Committee for the Western Pacific on “Implementing the International Health Regulations (2005) amendments” (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 21 Oct 2025

On 21 October 2025 in Nadi, Fiji, IFPMA delivered a statement at the 76th Session of the WHO Regional Committee for the Western Pacific on "Implementing the International Health Regulations (2005) amendments." ... About IFPMA ... ifpma.org.

Edit

78th Session of the WHO Regional Committee for South-East Asia on primary health care and universal health coverage (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 14 Oct 2025

On 14 October 2025 in Colombo, Sri Lanka, IFPMA delivered a statement on primary health care (PHC) and universal health coverage (UHC) at the 78th Session of the WHO Regional Committee for South-East Asia ... About IFPMA ... ifpma.org.

Edit

62nd Directing Council 77th Session of the Regional Committee of WHO for the Americas on the Prevention and Control of Noncommunicable Diseases (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Public Technologies 30 Sep 2025

On 30 September 2025 in Washington, D.C., IFPMA and FIFARMA delivered a statement on Agenda Item 4.5 Plan of Action on Noncommunicable Disease Prevention and Control 2025-2030 during the 77th Session of the Regional Committee of WHO for the Americas.

Podcasts:

Latest News for: ifpma

The innovation development and access pathway: A holistic approach to accelerating access to innovative medicines and vaccines (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

A new dawn in global health: UHC as the path toward national health stewardship (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Statement at the fourth meeting of the open-ended Intergovernmental Working Group (IGWG 4) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Considerations on the use of reliance in clinical trials review (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

WIPO Committee on IP and Development (CDIP 35): Technology Transfer (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Health as an economic priority – building on momentum driven by the G20 South Africa Presidency (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Biopharmaceutical CEOs Roundtable met in Berlin (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

WIPO Standing Committee on Patents (SCP 37): Technology Transfer (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

WIPO Standing Committee on Patents (SCP 37): Patents and health (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Statement on PABS Instrument at the third meeting of the open-ended Intergovernmental Working Group (IGWG 3) on the WHO Pandemic Agreement (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

75th WHO Regional Committee for Europe on the Action Plan for the Prevention and Control of Noncommunicable Diseases in the WHO European Region 2016–2025 (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Policy considerations for the development, regulation and adoption of biosimilars (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

76th Session of the WHO Regional Committee for the Western Pacific on “Implementing the International Health Regulations (2005) amendments” (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

78th Session of the WHO Regional Committee for South-East Asia on primary health care and universal health coverage (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

62nd Directing Council 77th Session of the Regional Committee of WHO for the Americas on the Prevention and Control of Noncommunicable Diseases (IFPMA - International Federation of Pharmaceuticals Manufacturers & Associations)

Article Search

EXPLORE WN.com